Hudson Bay Capital Management LP Seagen Inc. Transaction History

Hudson Bay Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $51 Million - $57.6 Million	266,420 Added 87.84%	569,711 $121 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $40.7 Million - $44.7 Million	216,877 Added 250.97%	303,291 $58.4 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $12.3 Million - $19.5 Million	-96,086 Reduced 52.65%	86,414 $17.5 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $11.2 Million - $13.2 Million	95,043 Added 108.67%	182,500 $23.5 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $5.35 Million - $7.12 Million	39,549 Added 82.55%	87,457 $12 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $860,469 - $1.42 Million	7,908 Added 19.77%	47,908 $8.48 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $299,025 - $394,625	2,500 Added 6.67%	40,000 $5.76 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $1.07 Million - $1.43 Million	7,500 Added 25.0%	37,500 $5.8 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $712,250 - $849,100	5,000 Added 20.0%	30,000 $5.09 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $1.35 Million - $1.61 Million	10,000 Added 66.67%	25,000 $3.95 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $2.06 Million - $2.86 Million	15,000 New	15,000 $2.08 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.